Oct
2026
Fiera Milano, Italy
Visit us
stand 11C65, Packaging & Drug Delivery
Zone
SHL Medical
Exhibitor at CPHI Milan 2026
About Us
Categories
-
Country/Region:Switzerland
-
Founded:1989
-
On CPHI since:2020
-
Certificates:2
-
Employees:5000+
Company types
Primary activities
Event information
CPHI Milan 2026
-
6 Oct 2026 - 8 Oct 2026
-
Fiera Milano, Italy
-
Visit us at stand 11C65, Packaging & Drug Delivery
Products Featured at CPHI Milan 2026
-
Product Quanta pen
Quanta pen injector is developed for once-weekly cardiometabolic therapies. It integrates an automatic mechanism with a fixed, multi-dose configuration, offering 4-6 doses in a single device.
Grounded in SHL Medical's experience in the field, Quanta provides pharma partners with another delivery opt... -
Product Reunite autoinjector
Reunite is an innovative, three-step, dual-chamber cartridge autoinjector, built with our market-proven Needle isolation Technology (NIT), to support automated reconstitution and delivery of lyophilized formulations. -
Product Molly modular platform autoinjector
Molly is a single-dose, pre-filled syringe-based autoinjector developed to help pharma and biotech companies reduce initial investments and expedite development timelines. Built on a modular platform technology, Molly is designed to meet the evolving requirements of future autoinjectors, such as intro... -
Product Molly 2.25 modular platform autoinjector
Molly 2.25 is a large-volume variant of the Molly autoinjector, developed to support the delivery of larger-volume biologics with the same 2-step operation. Built on a modular platform, Molly 2.25 enables high-volume manufacturing, faster development, and flexible design for unique branding needs... -
Product Maggie autoinjector
Maggie is a cartridge-based autoinjector built with our market-proven Needle Isolation Technology (NIT). Maggie accommodates a wider variety of formulation characteristics and volumes that are not possible with pre-filled syringe-based autoinjectors.
SHL Medical Resources (1)
-
Brochure Your drug delivery partner with proven track record
From design to mass production, SHL Medical's end-to-end device development infrastructure ensures the lasting value of self-injection systems that we design and develop with our customers. Our comprehensive in-house manufacturing capabilities and expertise include every core competency and value-added services across the product lifecycle. 35 years of pioneering the drug delivery industryOver 50 combination products launchedTop 25 bio/pharmaceutical companies in partnership Over 120M SHL devices reached patients worldwide




